[go: up one dir, main page]

MA22245A1 - Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues - Google Patents

Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues

Info

Publication number
MA22245A1
MA22245A1 MA22524A MA22524A MA22245A1 MA 22245 A1 MA22245 A1 MA 22245A1 MA 22524 A MA22524 A MA 22524A MA 22524 A MA22524 A MA 22524A MA 22245 A1 MA22245 A1 MA 22245A1
Authority
MA
Morocco
Prior art keywords
compositions
preparation
sustained release
release compositions
sustained
Prior art date
Application number
MA22524A
Other languages
English (en)
Inventor
Ruiz Jean-Marc
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of MA22245A1 publication Critical patent/MA22245A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
MA22524A 1990-08-01 1991-08-01 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues MA22245A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MA22245A1 true MA22245A1 (fr) 1992-04-01

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22524A MA22245A1 (fr) 1990-08-01 1991-08-01 Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues

Country Status (30)

Country Link
US (1) US5213812A (fr)
JP (1) JP2818704B2 (fr)
KR (1) KR920003962A (fr)
AT (1) AT396425B (fr)
AU (2) AU649696B2 (fr)
BE (1) BE1004772A3 (fr)
CA (1) CA2048270C (fr)
CH (1) CH682715A5 (fr)
DE (1) DE4125542A1 (fr)
DK (1) DK175756B1 (fr)
ES (1) ES2046083B1 (fr)
FI (1) FI104149B (fr)
FR (1) FR2665360B1 (fr)
GB (1) GB9016885D0 (fr)
GR (1) GR1001512B (fr)
HK (1) HK33294A (fr)
IE (1) IE65124B1 (fr)
IN (1) IN178446B (fr)
IT (1) IT1251788B (fr)
LU (1) LU87982A1 (fr)
MA (1) MA22245A1 (fr)
MY (1) MY107500A (fr)
NL (1) NL194637C (fr)
NO (1) NO300158B1 (fr)
NZ (1) NZ238981A (fr)
OA (1) OA09387A (fr)
PT (1) PT98497B (fr)
SE (1) SE505734C2 (fr)
TN (1) TNSN91067A1 (fr)
ZA (1) ZA915565B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
JP2930421B2 (ja) * 1994-02-28 1999-08-03 メディノヴァ メディカル コンサルティング ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤組成物、その製造方法及びその使用方法
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
CA2267930A1 (fr) * 1996-10-09 1998-04-16 Nobuyuki Takechi Procede de production d'une microparticule
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
AU3555599A (en) 1998-04-13 1999-11-01 Luminex Corporation Liquid labeling with fluorescent microparticles
AU770673B2 (en) * 1998-12-16 2004-02-26 Aventisub Ii Inc. Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ES2326209T3 (es) 2000-10-27 2009-10-05 Baxter Healthcare S.A. Produccion de microesferas.
DK1418890T3 (da) * 2001-08-16 2008-08-11 Baxter Int Drivmiddel-baserede mikropartikelformuleringer
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
MXPA06000720A (es) * 2003-07-18 2006-08-23 Baxter Int Metodos para fabricacion, usos y composiciones de particulas esfericas pequenas preparadas por separacion de fase controlada.
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
EP1646354A4 (fr) * 2003-07-22 2010-03-17 Baxter Int Petites particules spheriques de molecules organiques de faible poids moleculaire et procedes de preparation et d'utilisation correspondants
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
ES2442115T3 (es) * 2004-05-12 2014-02-10 Baxter International Inc. Microesferas que contienen oligonucleótidos, su utilización para la preparación de un medicamento para el tratamiento de la diabetes tipo 1
CN103393601A (zh) * 2004-05-12 2013-11-20 巴克斯特国际公司 含有蛋白并在高浓度蛋白下显示可注射性的微球体
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
ATE409025T1 (de) 2004-05-12 2008-10-15 Baxter Int Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
KR20070042177A (ko) * 2004-07-13 2007-04-20 알타이어나노 인코포레이티드 약물의 조절 방출을 위한 세라믹 구조체
KR20070042176A (ko) * 2004-07-13 2007-04-20 알타이어나노 인코포레이티드 약물 전용의 방지를 위한 세라믹 구조체
AU2005302273A1 (en) * 2004-10-29 2006-05-11 Adhesives Research, Inc. Microscopic tagging system for security identification
US20060260777A1 (en) * 2005-04-27 2006-11-23 Julia Rashba-Step Surface-modified microparticles and methods of forming and using the same
EP1928814A2 (fr) * 2005-08-23 2008-06-11 Altairnano, Inc Composition d'anatase-tio2 dopee au phosphore hautement catalytique et methodes de fabrication connexes
WO2007103820A1 (fr) * 2006-03-02 2007-09-13 Altairnano, Inc. Oxyde de fer dopé à l'indium nanostructuré
WO2007103812A1 (fr) * 2006-03-02 2007-09-13 Altairnano, Inc. Procédé de production à basse température de revêtements d'oxyde de fer nanostructurés
US20080008843A1 (en) * 2006-03-02 2008-01-10 Fred Ratel Method for Production of Metal Oxide Coatings
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
EP2647712A3 (fr) * 2006-08-04 2013-11-20 Baxter International Inc Composition à base de microsphères destinée à la prévention et/ou inversion de nouveaux cas de diabète auto-immun
US20080248122A1 (en) * 2006-10-06 2008-10-09 Baxter International Inc. Microencapsules Containing Surface-Modified Microparticles And Methods Of Forming And Using The Same
US9017697B2 (en) 2006-10-12 2015-04-28 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
WO2008128000A1 (fr) * 2007-04-12 2008-10-23 Altairnano, Inc. Remplacements en téflon et procédés de production apparentés
AU2008242842B2 (en) * 2007-04-17 2014-06-05 Baxter Healthcare Sa Nucleic acid microparticles for pulmonary delivery
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
PL2982753T3 (pl) 2008-04-18 2019-03-29 Baxter International Inc. Kompozycja na bazie mikrosfer do zapobiegania i/lub cofania nowego przypadku cukrzycy autoimmunologicznej
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
WO2010037021A2 (fr) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Filière et procédé de filage d’une fibre
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010132763A1 (fr) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fibre présentant une composition non uniforme et procédé de fabrication
CN102481375B (zh) * 2009-05-27 2017-06-06 西莱克塔生物科技公司 具有不同释放速率的纳米载体加工组分
WO2011038053A1 (fr) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Echafaudage de fibres tissulaires et procédé de réalisation
NO2575876T3 (fr) 2010-05-26 2018-05-05
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
EP2635596B8 (fr) 2010-11-01 2020-03-11 University of Technology Sydney Agents immuno-modulateurs et leurs utilisations
WO2013019658A2 (fr) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Nanosupports synthétiques comprenant des polymères comprenant de multiples agents immunomodulateurs
WO2015179918A1 (fr) 2014-05-27 2015-12-03 The University Of Queensland Modulation de stress cellulaire
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (fr) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
AU5939394A (en) 1994-06-02
TNSN91067A1 (fr) 1992-10-25
ITMI911953A0 (it) 1991-07-15
IN178446B (fr) 1997-05-03
NL194637C (nl) 2002-10-04
ES2046083A1 (es) 1994-01-16
PT98497B (pt) 1997-10-31
CH682715A5 (fr) 1993-11-15
DK141891A (da) 1992-02-02
JPH05178740A (ja) 1993-07-20
SE505734C2 (sv) 1997-10-06
HK33294A (en) 1994-04-22
CA2048270C (fr) 1997-02-25
SE9102249D0 (sv) 1991-07-26
NO300158B1 (no) 1997-04-21
FI913646A0 (fi) 1991-07-31
PT98497A (pt) 1992-06-30
GB9016885D0 (en) 1990-09-12
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
FI104149B1 (fi) 1999-11-30
GR910100330A (en) 1992-08-31
IE65124B1 (en) 1995-10-04
DK175756B1 (da) 2005-02-14
FI104149B (fi) 1999-11-30
OA09387A (fr) 1992-09-15
NL9101306A (nl) 1992-03-02
ITMI911953A1 (it) 1993-01-15
NO912986D0 (no) 1991-07-31
ZA915565B (en) 1992-04-29
BE1004772A3 (fr) 1993-01-26
IT1251788B (it) 1995-05-26
FI913646L (fi) 1992-02-02
AU8146691A (en) 1992-02-06
DK141891D0 (da) 1991-07-31
FR2665360A1 (fr) 1992-02-07
DE4125542A1 (de) 1992-02-06
LU87982A1 (fr) 1992-04-15
GR1001512B (el) 1994-02-28
KR920003962A (ko) 1992-03-27
NZ238981A (en) 1992-11-25
US5213812A (en) 1993-05-25
ATA152591A (de) 1993-01-15
ES2046083B1 (es) 1994-08-01
CA2048270A1 (fr) 1992-02-02
AT396425B (de) 1993-09-27
AU666808B2 (en) 1996-02-22
FR2665360B1 (fr) 1995-02-10
MY107500A (en) 1995-12-30
AU649696B2 (en) 1994-06-02
JP2818704B2 (ja) 1998-10-30
SE9102249L (sv) 1992-02-02
IE912700A1 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
MA22245A1 (fr) Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues
FI914174A7 (fi) Menetelmä piperidyylialkyyliamiinien valmistamiseksi
FI914905L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
NO914091D0 (no) Fremgangsmaate for fremstilling av hydroksylerte inhibitorer for hiv-reverstranskriptase
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
FI911713L (fi) Menetelmä stereokemiallisesti puhtaiden ergoliini-8-karboksiamidien valmistamiseksi
NO941659D0 (no) Fremgangsmåte for fremstilling av aluminoksaner
ID862B (id) Proses pembuatan komposisi-komposisi katalis
FI920018A7 (fi) Menetelmä 3-eksometyleenikefaamisulfoksidiestereiden valmistamiseksi
NO301716B1 (no) Fremgangsmåte for fremstilling av kalsium-L-askorbat-2-fosfat
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
FI901770A0 (fi) Menetelmä alkalimetallifosfaatin valmistamiseksi
FI910353L (fi) Jatkuva menetelmä tetrafosforipolysulfidien valmistamiseksi
FI913464A7 (fi) Menetelmä 1-hydroksimetyylipyratsolien valmistamiseksi
FI902417A7 (fi) Menetelmä 3-eksometyleenikefaamisulfoksidiesterien valmistamiseksi
FI923866A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
FI902590A7 (fi) Menetelmä 2-oksoindoli-1-karboksamidien valmistamiseksi
FI910662A7 (fi) Menetelmä 7-amino-3-metoksimetyyli-kef-3-emi-4-karboksyylihapon valmistamiseksi
FI953617A7 (fi) Menetelmä substituoitujen 4-hydroksikumariinien valmistamiseksi
FI940338L (fi) Menetelmä 13alfa-sinnamoyylibakkatiini III:n tai -10-desasetyylibakkatiini III:n valmistamiseksi
FI913656A7 (fi) Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
FI943660A7 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
FI913414A7 (fi) Menetelmä 2-hydroksi-3-halogeeni-5-nitro-pyridiinien valmistamiseksi